• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

A-366

CAS No. 1527503-11-2

A-366 ( A366 )

产品货号. M12140 CAS No. 1527503-11-2

A-366 是一种有效的、高选择性的组蛋白甲基转移酶 G9a/GLP 抑制剂,IC50 为 3/38 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥348 有现货
5MG ¥551 有现货
10MG ¥745 有现货
25MG ¥1774 有现货
50MG ¥3062 有现货
100MG ¥4520 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    A-366
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A-366 是一种有效的、高选择性的组蛋白甲基转移酶 G9a/GLP 抑制剂,IC50 为 3/38 nM。
  • 产品描述
    A-366 is a potent, highly selective inhibitor of histone methyltransferase G9a/GLP with IC50 of 3/38 nM, >1,000-fold selectivity for G9a over 21 other methyltransferases; effects a clear reduction in H3K9 methylation in cells, shows significantly less cytotoxic effects on the growth of tumor cell lines compared to other known G9a/GLP small molecule inhibitors despite equivalent cellular activity on methylation of H3K9me2 (H3K9me2 cellular EC50=0.3 uM); induces differentiation and affects viability in MV4;11 cells, demonstrates growth inhibition in vivo consistent with the profile of H3K9me2 reduction in flank xenograft leukemia model.
  • 体外实验
    A-366 (0.01-10 μM; 14 days) induces differentiation and affects viability in MV4;11 cells.A-366 (0.3-3 μM; 72 hours) reduces the total levels of H3K9me2 in a time and concentration dependent manner with a cellular EC50 of ~300 nM in PC-3 prostate adenocarcinoma cells. A-366 (0.01-10 μM; 4 days; HL-60 cells) results in a dose-dependent differentiation and a corresponding decrease in proliferation. DNA content analysis of A-366-treated HL-60 cells showed an accumulation of cells in G1 consistent with cytostasis. Cell Viability AssayCell Line:MV4;11 cells Concentration:0.01-10 μM Incubation Time:14 days Result:Resulted in inhibited proliferation and a decrease in viability corresponding to the dose response observed for CD11b staining.
  • 体内实验
    A-366 (30 mg/kg; osmotic mini-pump; daily for 14 days) treatment of MV4;11 xenografts elicits growth inhibition. Animal Model:6-8 week old SCID-beige female mice (MV4;11 xenografts)Dosage:30 mg/kg Administration:By osmotic mini-pump; daily for 14 days Result:A modest 45% tumor growth inhibition resulting from A-366 treatment in this model.
  • 同义词
    A366
  • 通路
    Chromatin/Epigenetic
  • 靶点
    HMTase
  • 受体
    G9a/GLP
  • 研究领域
    Other Indications
  • 适应症
    ——

化学信息

  • CAS Number
    1527503-11-2
  • 分子量
    329.4366
  • 分子式
    C19H27N3O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    NC(C12CCC1)=NC3=C2C=C(OC)C(OCCCN4CCCC4)=C3
  • 化学全称
    Spiro[cyclobutane-1,3'-[3H]indol]-2'-amine, 5'-methoxy-6'-[3-(1-pyrrolidinyl)propoxy]-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Sweis RF, et al. ACS Med Chem Lett. 2014 Jan 2;5(2):205-9. 2. Pappano WN, et al. PLoS One. 2015 Jul 6;10(7):e0131716. 3. Agarwal P, et al. Cancer Lett. 2016 Oct 1;380(2):467-75.
产品手册
关联产品
  • EPZ-031686

    一种有效的、选择性的小分子 SMYD3 抑制剂(Biochem IC50=3 nM;Cell IC50= 36 nM)。

  • OTS193320

    OTS193320 (OTS-193320) 是蛋白质甲基转移酶 SUV39H2 的有效抑制剂,IC50 为 22.2 nM。

  • MM-589

    一种高效、细胞渗透性的 WDR5-MLL 相互作用抑制剂,IC50 为 0.9 nM,Ki 为 <1 nM。